Leon Bichmann
Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues.
Kubiniok P, Marcu A, Bichmann L, Kuchenbecker L, Schuster H, Hamelin D, Duquette J, Kovalchik K, Wessling L, Kohlbacher O, Rammensee H, Neidert M, Sirois I, Caron E. Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues. iScience 2022; 25:103768.
18.01.2022Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues.
18.01.2022iScience 2022; 25:103768
Kubiniok Peter, Marcu Ana, Bichmann Leon, Kuchenbecker Leon, Schuster Heiko, Hamelin David J, Duquette Jérôme D, Kovalchik Kevin A, Wessling Laura, Kohlbacher Oliver, Rammensee Hans-Georg, Neidert Marian C, Sirois Isabelle, Caron Etienne
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
Marcu A, Walz J, Velz J, Moch H, Regli L, Silginer M, Weller M, Löffler M, Erhard F, Schlosser A, Kohlbacher O, Stevanovic S, Rammensee H, Kapolou K, Martin R, Hauri-Hohl M, Bichmann L, Kuchenbecker L, Kowalewski D, Freudenmann L, Backert L, Mühlenbruch L, Szolek A, Lübke M, Wagner P, Engler T, Matovina S, Wang J, Neidert M. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy. J Immunother Cancer 2021; 9
01.01.2021HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
01.01.2021J Immunother Cancer 2021; 9
Marcu Ana, Walz Juliane Sarah, Velz Julia, Moch Holger, Regli Luca, Silginer Manuela, Weller Michael, Löffler Markus W, Erhard Florian, Schlosser Andreas, Kohlbacher Oliver, Stevanovic Stefan, Rammensee Hans-Georg, Kapolou Konstantina, Martin Roland, Hauri-Hohl Mathias, Bichmann Leon, Kuchenbecker Leon, Kowalewski Daniel Johannes, Freudenmann Lena Katharina, Backert Linus, Mühlenbruch Lena, Szolek András, Lübke Maren, Wagner Philipp, Engler Tobias, Matovina Sabine, Wang Jian, Neidert Marian Christoph
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
Bilich T, Vucinic V, Niederwieser D, Bauer J, Märklin M, Peper J, Klein R, Kohlbacher O, Kanz L, Rammensee H, Stevanovic S, Brümmendorf T, Schemionek M, Rieth J, Nelde A, Bichmann L, Roerden M, Salih H, Kowalewski D, Schuster H, Tsou C, Marcu A, Neidert M, Lübke M, Walz J. The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy. Blood 2018; 133:550-565.
10.12.2018The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
10.12.2018Blood 2018; 133:550-565
Bilich Tatjana, Vucinic Vladan, Niederwieser Dietger, Bauer Jens, Märklin Melanie, Peper Janet K, Klein Reinhild, Kohlbacher Oliver, Kanz Lothar, Rammensee Hans-Georg, Stevanovic Stefan, Brümmendorf Tim H, Schemionek Mirle, Rieth Jonas, Nelde Annika, Bichmann Leon, Roerden Malte, Salih Helmut R, Kowalewski Daniel J, Schuster Heiko, Tsou Chih-Chiang, Marcu Ana, Neidert Marian Christoph, Lübke Maren, Walz Juliane S